20.05 : 2012 .

ԙ, 2012. 3% 3,067 . . 13% 7% , 191,034 . (6,165 . .) (.1). - (2,39 .) 2,67 . . 12 2012. 57,22 . - 70% 49% .

-10 2012. (.1). : PHARMSTANDART (+17%), SANOFI-AVENTIS (+13%) SANDOZ (+7%), STADA (+11%), TEVA (+15%), JOHNSON & JOHNSON (+16%) NYCOMED/TAKEDA (+5%). . MENARINI (+2%) - , 6 , BAYER (+20%) NOVARTIS (+18%). , , 43,3%.

LINEX (+14%), LASOLVAN (+6%) ANAFERON (+5%) - 3 5 (.2). ESSENTIALE N (+22%), -10 ARBIDOL 20% 2 . , OCILLOCOCCINUM (-5%) MEZYM FORTE (-3%), , . , , . , 8 , NO SPA (+14%). -10 KAGOCEL ( 2,2 ) PENTALGIN ( 4,6 ).

14 9 CHONDROITINSULFURIC ACID + GLUCOSAMINE (+26%) (.3). , -10. , , XYLOMETAZOLINE (+25%) IBUPROFEN (+19%), PHOSPHOLIPIDS (+21%) - 4 2 . PARACETAMOL + ASCORBIC ACID + PHENIRAMINE (+9%).